DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Similar documents
EUCAST recommended strains for internal quality control

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS

2016 Antibiotic Susceptibility Report

Antimicrobial Pharmacodynamics

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

Concise Antibiogram Toolkit Background

Intrinsic, implied and default resistance

CONTAGIOUS COMMENTS Department of Epidemiology

European Committee on Antimicrobial Susceptibility Testing

2015 Antibiotic Susceptibility Report

BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016)

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Antimicrobial Chemotherapy

Staph Cases. Case #1

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

Understanding the Hospital Antibiogram

Preserve the Power of Antibiotics

Principles of Infectious Disease. Dr. Ezra Levy CSUHS PA Program

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی

Recommendations to take it forward!

Antimicrobial Susceptibility Testing: The Basics

Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

ESCMID Online Lecture Library. by author

European Committee on Antimicrobial Susceptibility Testing

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Background and Plan of Analysis

Antimicrobial Susceptibility Testing: Advanced Course

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

OPAT discharge navigator and laboratory monitoring Select OPAT button for ALL patients that discharge on intravenous antimicrobials

Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV

CUMULATIVE ANTIBIOGRAM

Antibiotic Updates: Part II

CF WELL Pharmacology: Microbiology & Antibiotics

Infectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Antibiotic Pharmacokinetics and Pharmacodynamics for Laboratory Professionals

Introduction to Pharmacokinetics and Pharmacodynamics

Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges

* gender factor (male=1, female=0.85)

EARS Net Report, Quarter

Initial Management of Infections in the Era of Enhanced Antimicrobial Resistance

Antimicrobial Stewardship Strategy: Antibiograms

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* ...

Antimicrobial Susceptibility Patterns

Antimicrobial Stewardship Program

Intra-Abdominal Infections. Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018

Disclosures. Principles of Antimicrobial Therapy. Obtaining an Accurate Diagnosis Obtain specimens PRIOR to initiating antimicrobials

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

What s new in EUCAST methods?

4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES

Should we test Clostridium difficile for antimicrobial resistance? by author

CONTAGIOUS COMMENTS Department of Epidemiology

CONTAGIOUS COMMENTS Department of Epidemiology

Interactive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe

Examples of Antimicrobial Stewardship Interventions: a couple of starter projects

Appropriate antimicrobial therapy in HAP: What does this mean?

Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review

DETERMINING CORRECT DOSING REGIMENS OF ANTIBIOTICS BASED ON THE THEIR BACTERICIDAL ACTIVITY*

What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups. by author. Gunnar Kahlmeter, Derek Brown

Pharmacokinetics and Pharmacodynamics of Antimicrobials in the Critically Ill Patient

Jerome J Schentag, Pharm D

Streptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance

Antimicrobial Therapy

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

Contribution of pharmacokinetic and pharmacodynamic parameters of antibiotics in the treatment of resistant bacterial infections

Updates on the Management of Hospital Acquired Infections and Resistant Organisms

Updates on the Management of Hospital Acquired Infections and Resistant Organisms

Discussion Points. Decisions in Selecting Antibiotics

Antimicrobial susceptibility

Antibiotic Updates: Part I

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Introduction to Antimicrobial Therapy

microbiology testing services

What s next in the antibiotic pipeline?

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018

Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes

January 2014 Vol. 34 No. 1

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

Antimicrobial Update. Vicky Dudas, Pharm.D. Associate Clinical Professor of Pharmacy Director, Antimicrobial Management Program UCSF Medical Center

Other Beta - lactam Antibiotics

InPHARMation. Pharmacy and Therapeutics Committee Update May 23 rd, 2018 Meeting

CONTAGIOUS COMMENTS Department of Epidemiology

Measurement of Antimicrobial Drug Use. Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS DASON Liaison Pharmacist

Update on Resistance and Epidemiology of Nosocomial Respiratory Pathogens in Asia. Po-Ren Hsueh. National Taiwan University Hospital

EUCAST-and CLSI potency NEO-SENSITABS

Surveillance for Antimicrobial Resistance and Preparation of an Enhanced Antibiogram at the Local Level. janet hindler

CHSPSC, LLC Antimicrobial Stewardship Education Series

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS

Antibiotic Stewardship Program (ASP) CHRISTUS SETX

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre

Principles of Antimicrobial Therapy

5/4/2018. Multidrug Resistant Organisms (MDROs) Objectives. Outline. Define a multi-drug resistant organism (MDRO)

Defining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate Confirmation Testing

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

Transcription:

DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this photo and/or video. If you don t want your photo taken, please let us know. Thank you! ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Interpretation of a Culture and Sensitivity Report JESSICA THOMPSON, PHARMD, BCPS (AQ-ID)

Goals Briefly review the interpretation of culture and sensitivity reports

Example C/S report Tracheal aspirate: Pseudomonas aeruginosa Antibiotic MIC Interpretation Aztreonam 8 S Ceftriaxone > 32 R Ceftazidime 4 S Ciprofloxacin 1 S Gentamicin 2 S Meropenem 1 S Piperacillin/tazobactam 16 S

Interpreting a C/S Report WHAT IT TELLS YOU Identifies bacteria/fungus present (most of the time) Sensitivity results based on lab data Human vs lab WHAT IT DOES NOT TELL YOU Does not identify infection vs colonization vs contamination Don t treat colonization or contamination Does not tell you which antibiotic to use

Susceptibility testing is an in vitro phenomenon and does not necessarily reflect or predict in vivo efficacy. Susceptibility testing is subject to great variability depending on pathogen tested, media used, conditions of incubation, and method of accessing bacterial growth BURKE A CUNHA

Example C/S report Tracheal aspirate: Pseudomonas aeruginosa Antibiotic MIC Interpretation Aztreonam 8 S Ceftriaxone > 32 R Ceftazidime 4 S Ciprofloxacin 1 S Gentamicin 2 S Meropenem 1 S Piperacillin/tazobactam 16 S

definitions MIC Minimum concentration of an antibiotic needed to inhibit visible growth of a single isolate of an organism Important for definitive treatment of an individual patient Breakpoint Discriminatory concentrations used in the interpretation of results of susceptibility testing to define isolates as susceptible, intermediate, or resistant (determined by various organizations - FDA, CLSI, EUCAST)

Which antibiotic should you use? Tracheal aspirate: Pseudomonas aeruginosa Antibiotic MIC Interpretation Aztreonam 8 S Ceftriaxone > 32 R Ceftazidime 4 S Ciprofloxacin 1 S Gentamicin 2 S Meropenem 1 S Piperacillin/tazobactam 16 S

Rule #1 ALWAYS START WITH A BETA-LACTAM IF POSSIBLE, ESPECIALLY IN SEVERE INFECTIONS They have the best data supporting their use and are in general excellent drugs Exception: atypical infections

Rule #2 DO NOT COMPARE MICS BETWEEN DRUGS Each antibiotic has different pharmacokinetics Different serum concentrations Different tissue concentrations Each antibiotic has different goal pharmacodynamic parameters Time vs concentration vs AUC/MIC dependent

Rule #3 Exceptions IF YOU CAN USE THE DRUG (NOTE EXCEPTIONS BELOW) Drug doesn t get to the site of action Drug doesn t achieve its goal pharmacodynamics parameters Drug doesn t have inducible resistance Patient-specific factors Drug cost

Rule #4 MICROBIOLOGY ALWAYS HAS MORE INFORMATION THAN WHAT IS REPORTED They may have results before they are reported in the computer Antibiotics may be suppressed They can perform additional testing

Assessment question #1 Blood culture: Enterococcus faecalis Antibiotic MIC Interpretation Ampicillin <= 2 S Daptomycin 1 S Penicillin 2 S Vancomycin 2 S Which antibiotic should you use?

Assessment question #1 Rule #1: Always start with a betalactam if possible Rule #2: Do not compare MICs between drugs Rule #3: If <= you can use the drug with some exceptions Rule #4: Micro always has more information Blood culture: Enterococcus faecalis Antibiotic MIC Interpretation Ampicillin <= 2 S Daptomycin 1 S Penicillin 2 S Vancomycin 2 S

Assessment question #1 Rule #1: Always start with a beta-lactam if possible The drug of choice for ampicillin-sensitive enterococcus is Ampicillin Rule #2: Do not compare MICs between drugs Daptomycin is not better than ampicillin because the MIC is lower Amicillin is still the drug of choice if sensitive Rule #3: If <= you can use the drug with some exceptions True; cost effectiveness: ampicillin > vancomycin > daptomycin Rule #4: Microbiology always has more information that what is reported Microbiology also tests linezolid, which is the only oral option for treatment of this bacteremia (ampicillin is still preferred) Answer: AMPICILLIN 2 gm IV q4h

Assessment question #2 Which antibiotic should you use?

Assessment question #2 You need more information Cystitis or pyelonephritis? If cystitis, is it a male or female? If female, how old? Let s assume this is CYSTITIS in a YOUNG ADULT FEMALE with no comorbid conditions Do you want IV or PO?

Assessment question #2 Rule #1: Always start with a beta-lactam if possible Cefotetan and meropenem are the only sensitive beta-lactams Rule #2: Do not compare MICs between drugs Rule #3: If <= you can use the drug with some exceptions Exceptions Cefotetan should not be used for ESBL-producing organisms and is IV Meropenem is appropriate but is IV Ciprofloxacin is resistant so levofloxacin should not be used Tigecycline has poor urine penetration and is IV Nitrofurantoin Rule #4: Microbiology always has more information that what is reported Fosfomycin can also be tested but is expensive

Assessment question #2 Answer: Macrobid 100 mg PO BID x 5 days

Summary There is always more to the evaluation that just an S Use a beta-lactam if at all possible Never use the smallest number just because it is the smallest number Know the exceptions Ask for help if unsure